1. Home
  2. AKBA vs CYH Comparison

AKBA vs CYH Comparison

Compare AKBA & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.01

Market Cap

375.0M

Sector

Health Care

ML Signal

HOLD

Logo Community Health Systems Inc.

CYH

Community Health Systems Inc.

HOLD

Current Price

$2.78

Market Cap

432.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
CYH
Founded
2007
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
375.0M
432.2M
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
AKBA
CYH
Price
$1.01
$2.78
Analyst Decision
Strong Buy
Hold
Analyst Count
3
6
Target Price
$4.67
$3.28
AVG Volume (30 Days)
5.0M
1.8M
Earning Date
05-07-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
93.94
196.67
EPS
N/A
N/A
Revenue
N/A
$12,485,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$2.39
52 Week High
$4.08
$4.43

Technical Indicators

Market Signals
Indicator
AKBA
CYH
Relative Strength Index (RSI) 34.96 43.44
Support Level N/A $2.41
Resistance Level $1.56 $2.81
Average True Range (ATR) 0.08 0.11
MACD -0.03 0.00
Stochastic Oscillator 19.55 29.51

Price Performance

Historical Comparison
AKBA
CYH

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: